Corcept Therapeutics
CORT
#2200
Rank
C$10.18 B
Marketcap
$97.19
Share price
-4.26%
Change (1 day)
235.76%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of September 2024 : C$0.55 Billion

According to Corcept Therapeutics 's latest financial reports the company has C$0.55 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.48 B-16.62%
2022-12-31C$0.58 B105.61%
2021-12-31C$0.28 B-49.3%
2020-12-31C$0.56 B55.91%
2019-12-31C$0.36 B27.97%
2018-12-31C$0.28 B152.43%
2017-12-31C$0.11 B61.1%
2016-12-31C$69.25 M23.47%
2015-12-31C$56.09 M99.33%
2014-12-31C$28.13 M-51.83%
2013-12-31C$58.41 M-36.85%
2012-12-31C$92.51 M129.46%
2011-12-31C$40.31 M64.1%
2010-12-31C$24.56 M-2.17%
2009-12-31C$25.11 M12.81%
2008-12-31C$22.26 M28.5%
2007-12-31C$17.32 M57.36%
2006-12-31C$11 M-67.48%
2005-12-31C$33.85 M-24.63%
2004-12-31C$44.92 M199.12%
2003-12-31C$15.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$29.47 B 5,236.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.75 B 2,028.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$20.36 B 3,586.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$5.11 B 825.08%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.45 B 2,516.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$21.19 B 3,736.87%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.21 B-61.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.36 B-33.85%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.35 B 144.64%๐Ÿ‡บ๐Ÿ‡ธ USA